Water → HCID 69479606, compound
Reaction equation
[Cl:1][C:2]1[N:3]([CH2:10][C@:11]2([CH3:14])[CH2:13][O:12]2)[CH:4]=[C:5]([N+:7]([O-:9])=[O:8])[N:6]=1.[F:15][C:16]([F:32])([F:31])[C:17]1[CH:30]=[CH:29][C:20]([CH2:21][O:22][CH:23]2[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]2)=[CH:19][CH:18]=1.O>CN(C=O)C>[Cl:1][C:2]1[N:3]([CH2:10][C@@:11]([CH3:14])([OH:12])[CH2:13][N:26]2[CH2:25][CH2:24][CH:23]([O:22][CH2:21][C:20]3[CH:29]=[CH:30][C:17]([C:16]([F:15])([F:31])[F:32])=[CH:18][CH:19]=3)[CH2:28][CH2:27]2)[CH:4]=[C:5]([N+:7]([O-:9])=[O:8])[N:6]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
(R)-2-Chloro-1-(2-methyloxiran-2-ylmethyl)-4-nitroimidazole prepared in Example 12 (700 mg, 3.22 mmol) and 4-(4-trifluoromethylbenzyloxy)piperidine (1.09 g, 4.86 mol) in DMF (10 ml) were stirred at 70-75° C. for 4 hours. The reaction mixture was allowed to return to room temperature, poured into water and extracted with ethyl acetate. The extract was washed with a saturated saline solution, dried over magnesium sulfate and then filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (methylene chloride/methanol=50/1) to afford (S)-1-(2-chloro-4-nitroimidazol-1-yl)-2-methyl-3-[4-(4-trifluoromethylbenzyloxy)piperidin-1-yl]propan-2-ol (1.36 g, yield 87%) as a yellow oil.
Workup
- customto return to room temperature
- extractionextracted with ethyl acetate
- washThe extract was washed with a saturated saline solution
- dry with materialdried over magnesium sulfate
- filtrationfiltered
- concentrationThe filtrate was concentrated under reduced pressure
- customthe residue was purified by silica gel column chromatography (methylene chloride/methanol=50/1)
Sources & evidence
- ORD record
- ord-6e4084655f69487dae75b297a2064310
- Source dataset
- uspto-grants-2007_08
- Patent number
- US07262212B2
Reaction notes
Loading…